Pharming Group N.V.

NASDAQ: PHAR · Real-Time Price · USD
11.75
0.37 (3.25%)
At close: Aug 15, 2025, 3:50 PM
11.60
-1.28%
After-hours: Aug 15, 2025, 05:26 PM EDT

Pharming Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
297.2M 245.32M 205.62M 189.85M
Cost of Revenue
35.4M 25.21M 17.56M 20.18M
Gross Profit
261.8M 220.1M 188.06M 169.67M
Operating Income
-8.62M -4.88M 18.23M 27.84M
Interest Income
5.72M 3.53M 85.05K 52.92K
Pretax Income
-8.2M -12.01M 14.99M 22.03M
Net Income
-10.64M -10.55M 13.67M 16M
Selling & General & Admin
99.22M 87.5M 131.82M 92.05M
Research & Development
83.15M 68.91M 52.53M 67.18M
Other Expenses
88.06M 69.08M -14.52M -2.5M
Operating Expenses
270.42M 225.49M 169.83M 156.72M
Interest Expense
8.74M 5.96M 5.47M 6.18M
Selling & Marketing Expenses
7.13M 6.82M 85.8M 56.75M
Cost & Expenses
305.82M 250.7M 187.39M 176.91M
Income Tax Expense
2.43M -1.46M 1.31M 6.76M
Shares Outstanding (Basic)
68.92M 65.7M 88.39M 87.64M
Shares Outstanding (Diluted)
68.92M 65.7M 88.39M 87.64M
EPS (Basic)
-0.15 -0.14 0.17 0.20
EPS (Diluted)
-0.15 -0.14 0.15 0.18
EBITDA
16.32M 9.88M 33.53M 48.78M
EBIT
245K -6.05M 20.34M 29.17M
Depreciation & Amortization
16.07M 15.93M 13.19M 19.61M